Literature DB >> 18539155

Functional properties and active-site topographies of factor X Gla- and prothrombin Gla-domain chimeras of activated protein C.

Shabir H Qureshi1, Likui Yang, Chandrashekhara Manithody, Jong-Sup Bae, Alireza R Rezaie.   

Abstract

Substitution of the Gla-domain of activated protein C (APC) with the Gla-domain of prothrombin (APC-PTGla) improves the anticoagulant activity of APC independent of protein S. Previous FRET studies showed that this substitution alters the active-site topography of this mutant, rendering it identical to the active site of the APC-protein S complex. In this study, we characterized the functional properties and the active-site topography of another APC chimera containing the Gla-domain of factor X (APC-FXGla). We discovered that the anticoagulant activity of this mutant was similarly improved independent of protein S. The average distance of the closest approach (L) between the donor dye fluorescein attached to the active site of APC derivatives and the acceptor dye octadecylrhodamine incorporated into PC/PS vesicles was determined to be 99 A for APC and 84-86 A for both APC-PTGla and APC-FXGla. Protein S minimally influenced the L values of the APC chimeras, however, it lowered this value to 87 A for wild-type APC. Further studies revealed that neither chimera elicits a protective signaling response in the TNF-alpha-activated endothelial cells. These results suggest that unique structural features within the Gla-domain of APC enable the protease to interact with endothelial protein C receptor in the antiinflammatory pathway, while the same features also cause an inherently lower specific activity for APC in the anticoagulant pathway. This adaptation has made APC a cofactor-dependent protease, requiring the cofactor function of protein S for its optimal anticoagulant function, which appears to involve the alteration of the active-site topography of APC above the membrane surface.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18539155      PMCID: PMC2575086          DOI: 10.1016/j.bbagen.2008.05.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  33 in total

1.  Human protein C and activated protein C Components of the human anticoagulation system.

Authors:  F J Castellino
Journal:  Trends Cardiovasc Med       Date:  1995 Mar-Apr       Impact factor: 6.677

Review 2.  Structure and function of protein C.

Authors:  J Stenflo
Journal:  Semin Thromb Hemost       Date:  1984-04       Impact factor: 4.180

3.  Importance of protein S and phospholipid for activated protein C-mediated cleavages in factor Va.

Authors:  Eva A Norstrøm; Mårten Steen; Sinh Tran; Björn Dahlbäck
Journal:  J Biol Chem       Date:  2003-04-21       Impact factor: 5.157

Review 4.  Role of coagulation inhibitors in inflammation.

Authors:  C T Esmon
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

5.  A chimeric protein C containing the prothrombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificity.

Authors:  M D Smirnov; O Safa; L Regan; T Mather; D J Stearns-Kurosawa; S Kurosawa; A R Rezaie; N L Esmon; C T Esmon
Journal:  J Biol Chem       Date:  1998-04-10       Impact factor: 5.157

6.  Relocating the active site of activated protein C eliminates the need for its protein S cofactor. A fluorescence resonance energy transfer study.

Authors:  S Yegneswaran; M D Smirnov; O Safa; N L Esmon; C T Esmon; A E Johnson
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

7.  Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation.

Authors:  Clemens Feistritzer; Matthias Riewald
Journal:  Blood       Date:  2004-12-30       Impact factor: 22.113

8.  Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke.

Authors:  M Shibata; S R Kumar; A Amar; J A Fernandez; F Hofman; J H Griffin; B V Zlokovic
Journal:  Circulation       Date:  2001-04-03       Impact factor: 29.690

9.  The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells.

Authors:  Jong-Sup Bae; Likui Yang; Chandrashekhara Manithody; Alireza R Rezaie
Journal:  Blood       Date:  2007-09-06       Impact factor: 22.113

10.  Enhancement of human protein C function by site-directed mutagenesis of the gamma-carboxyglutamic acid domain.

Authors:  L Shen; A M Shah; B Dahlbäck; G L Nelsestuen
Journal:  J Biol Chem       Date:  1998-11-20       Impact factor: 5.157

View more
  1 in total

1.  Coagulation factor V mediates inhibition of tissue factor signaling by activated protein C in mice.

Authors:  Hai Po H Liang; Edward J Kerschen; Sreemanti Basu; Irene Hernandez; Mark Zogg; Shuang Jia; Martin J Hessner; Raffaella Toso; Alireza R Rezaie; José A Fernández; Rodney M Camire; Wolfram Ruf; John H Griffin; Hartmut Weiler
Journal:  Blood       Date:  2015-09-04       Impact factor: 22.113

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.